abstract |
Provided herein are arylsulfonamides and pharmaceutical compositions thereof useful for modulating CCR3 activity. Also provided herein are methods of their use to treat, prevent, or ameliorate one or more symptoms of a CCR3-mediated disorder, disease, or condition. [Selection figure] None |